comparemela.com

Latest Breaking News On - Institutional investors weigh in on evolent health - Page 1 : comparemela.com

Evolent Health (NYSE:EVH) Receives New Coverage from Analysts at Citigroup

Citigroup initiated coverage on shares of Evolent Health (NYSE:EVH – Get Free Report) in a research report issued on Monday, Marketbeat.com reports. The brokerage set a “buy” rating and a $40.00 price target on the technology company’s stock. Citigroup’s price objective points to a potential upside of 32.76% from the stock’s previous close. A number […]

Evolent Health (NYSE:EVH) Price Target Cut to $45 00 by Analysts at Canaccord Genuity Group

Evolent Health (NYSE:EVH – Free Report) had its target price trimmed by Canaccord Genuity Group from $47.00 to $45.00 in a research report sent to investors on Friday morning, Benzinga reports. The firm currently has a buy rating on the technology company’s stock. A number of other equities analysts also recently weighed in on EVH. […]

Evolent Health (NYSE:EVH) Shares Gap Up to $29 77

Evolent Health, Inc. (NYSE:EVH – Get Free Report)’s stock price gapped up before the market opened on Friday . The stock had previously closed at $29.77, but opened at $32.75. Evolent Health shares last traded at $31.81, with a volume of 258,344 shares trading hands. Wall Street Analyst Weigh In Several research firms recently weighed […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.